Skip to main content
Clinical Trials/NCT03202082
NCT03202082
Unknown
Phase 2

Impact of Neuropsychological Evaluation on Epilepsy Treatment

University of South Florida1 site in 1 country100 target enrollmentJuly 1, 2015
ConditionsEpilepsy

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Epilepsy
Sponsor
University of South Florida
Enrollment
100
Locations
1
Primary Endpoint
Epilepsy Outcome Study Survey
Last Updated
8 years ago

Overview

Brief Summary

The present study aims to expand the evidence base of neuropsychological services in the context of medical management of epilepsy, examining whether treatment outcome and patient satisfaction with medical care are significantly improved when neuropsychological evaluation is included as an additional component of medical care within a comprehensive epilepsy center. All participants will complete an initial survey and a follow-up survey regarding views towards their epilepsy treatment. Participants will be randomized into one of two groups. One group will be given a neuropsychological battery in addition to the survey. The primary study hypothesis is that the addition of neuropsychological services to treatment-as-usual will result in significant improvements in (a) satisfaction with medical care, (b) patient perceived treatment outcome, and (c) physician-rated medical compliance. The secondary hypothesis is that participants who undergo neuropsychological evaluation will be generally satisfied with their experience with neuropsychological services.

Registry
clinicaltrials.gov
Start Date
July 1, 2015
End Date
June 30, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • experiencing some degree of epilepsy-related symptoms, but not of such severity as to preclude them from being able to provide consent or undergo neuropsychological assessment (requiring extended inpatient treatment, severely aphasic, or MMSE score \< 25)

Exclusion Criteria

  • Previously undergone neuropsychological testing
  • Currently pursuing surgical treatment for epilepsy

Outcomes

Primary Outcomes

Epilepsy Outcome Study Survey

Time Frame: 2-4 months

A brief questionnaire regarding the participants views on their epilepsy treatment

Study Sites (1)

Loading locations...

Similar Trials